Showing 741 - 760 results of 80,813 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 1.16s Refine Results
  1. 741

    SPL decreases diabetes-induced oxidative stress in GL and PT. by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…SPL treatment prevents diabetes-induced increment in O<sub>2</sub><sup>●―</sup> production (A) by using nicotinamide adenine dinucleotide phosphate (NADPH) as substrate and, diphenyleneiodonium (DPI) as inhibitor, lipid peroxidation (B) and protein carbonylation (C) and decreased GSH content (D) in GL (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s003" target="_blank">S3 Fig</a>). …”
  2. 742
  3. 743
  4. 744
  5. 745
  6. 746
  7. 747
  8. 748

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…One hundred percent cell viability corresponds to the number of living cells incubated with transfecting agent only. Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”
  9. 749
  10. 750
  11. 751
  12. 752
  13. 753
  14. 754

    rAd-p53 induces apoptosis in HCC cell lines with increased Fbxw7 and decreased c-Myc and Cyclin E. by Kangsheng Tu (428934)

    Published 2013
    “…Quantification of RT-PCR for p53 and Fbxw7 indicated elevated mRNA levels for rAd-p53 infected Hep3B cells, whereas c-Myc and Cyclin E levels were not significantly decreased. …”
  15. 755
  16. 756
  17. 757

    Decreased TORC1 activates HPK-1 to extend longevity. by Ritika Das (4514968)

    Published 2017
    “…Representative images of <i>Phpk-1</i>::<i>HPK-1</i>::<i>GFP</i> neuronal expression in day 3 adult animals after treatment with control (A), <i>daf-2</i> (B), <i>rict-1</i> (C) and <i>daf-15</i> RNAi (D). …”
  18. 758
  19. 759
  20. 760